共 96 条
[1]
Bao Y(2023)Evaluation of GREM1 and THBS2 as prognostic markers in in non-small cell lung cancer J Cancer Res Clin Oncol 149 7849-7856
[2]
Yan E(2014)Thrombospondin-2 and extracellular matrix assembly Biochim Biophys Acta 1840 2396-2402
[3]
Wang N(2011)Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC) Clin Lung Cancer 12 172-179
[4]
Calabro NE(2020)Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer Technol Cancer Res Treat 19 1533033820964222-92264
[5]
Kristofik NJ(2017)RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer Oncotarget 8 92254-2160
[6]
Kyriakides TR(2017)Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations BMC Cancer 17 484-223
[7]
Cedres S(2019)The diagnostic performance of lysine(K)-specific demethylase 6B (KDM6B) in non-small cell lung cancer Artif Cells Nanomed Biotechnol 47 2155-2791
[8]
Nunez I(2023)Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status Cochrane Database Syst Rev 7 CD013382-171
[9]
Longo M(2017)The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer J Cancer Res Clin Oncol 143 215-2374
[10]
Chen L(2018)A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer Cancer Med 7 2783-599